Scarica l'app Stockscreener
11.92
2.94%
0.34
Dopo l'orario di chiusura:
11.92
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché OCUL Giù?
Forum
Previsione
Precedente Chiudi:
$11.58
Aprire:
$11.44
Volume 24 ore:
1.65M
Relative Volume:
0.75
Capitalizzazione di mercato:
$1.90B
Reddito:
$61.10M
Utile/perdita netta:
$-138.36M
Rapporto P/E:
-8.8296
EPS:
-1.35
Flusso di cassa netto:
$-90.59M
1 W Prestazione:
-2.38%
1M Prestazione:
+30.99%
6M Prestazione:
+54.81%
1 anno Prestazione:
+47.71%
Intervallo 1D:
$11.30
$12.05
Intervallo di 1 settimana:
$11.30
$12.35
Portata 52W:
$5.80
$12.35
Ocular Therapeutix Inc Stock (OCUL) Company Profile
Nome
Ocular Therapeutix Inc
Settore
Industria
Telefono
781-357-4000
Indirizzo
15 CROSBY DRIVE, BEDFORD, MA
Confronta OCUL con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
OCUL
Ocular Therapeutix Inc
|
11.92 | 1.84B | 61.10M | -138.36M | -90.59M | -1.35 |
|
VRTX
Vertex Pharmaceuticals Inc
|
462.13 | 117.32B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
558.87 | 58.89B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
401.80 | 51.14B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
673.80 | 41.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
299.01 | 32.59B | 3.81B | -644.79M | -669.77M | -6.24 |
Ocular Therapeutix Inc Stock (OCUL) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-04-08 | Iniziato | William Blair | Outperform |
| 2025-03-18 | Iniziato | RBC Capital Mkts | Outperform |
| 2025-03-11 | Iniziato | Needham | Buy |
| 2024-10-16 | Iniziato | Scotiabank | Sector Outperform |
| 2024-06-20 | Aggiornamento | TD Cowen | Hold → Buy |
| 2024-05-31 | Ripresa | Piper Sandler | Overweight |
| 2024-02-09 | Iniziato | BofA Securities | Buy |
| 2023-04-21 | Iniziato | Robert W. Baird | Outperform |
| 2022-08-10 | Ripresa | Berenberg | Buy |
| 2021-08-10 | Aggiornamento | H.C. Wainwright | Neutral → Buy |
| 2020-12-28 | Downgrade | H.C. Wainwright | Buy → Neutral |
| 2020-12-17 | Iniziato | Berenberg | Buy |
| 2020-11-13 | Reiterato | Raymond James | Strong Buy |
| 2020-08-10 | Reiterato | H.C. Wainwright | Buy |
| 2020-03-03 | Aggiornamento | Raymond James | Outperform → Strong Buy |
| 2019-05-21 | Downgrade | Cowen | Outperform → Market Perform |
| 2019-05-21 | Reiterato | H.C. Wainwright | Buy |
| 2019-05-21 | Downgrade | Raymond James | Strong Buy → Outperform |
| 2018-12-03 | Reiterato | Cantor Fitzgerald | Overweight |
| 2018-11-15 | Iniziato | Raymond James | Strong Buy |
| 2018-09-07 | Iniziato | Piper Jaffray | Overweight |
| 2017-10-24 | Iniziato | Guggenheim | Buy |
| 2017-07-26 | Iniziato | H.C. Wainwright | Buy |
| 2017-07-12 | Reiterato | Cantor Fitzgerald | Overweight |
| 2017-06-23 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2017-02-10 | Iniziato | Cantor Fitzgerald | Overweight |
| 2016-11-15 | Reiterato | RBC Capital Mkts | Outperform |
| 2016-08-11 | Iniziato | JMP Securities | Mkt Outperform |
| 2016-02-17 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2015-10-23 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2015-08-13 | Iniziato | Morgan Stanley | Overweight |
Mostra tutto
Ocular Therapeutix Inc Borsa (OCUL) Ultime notizie
Should I hold or sell Ocular Therapeutix Inc. stock in 2025Low Risk Alerts Backed By Experts - jammulinksnews.com
What are Ocular Therapeutix Inc. company’s key revenue driversRetirement Planning Review With Proven Results - jammulinksnews.com
When is Ocular Therapeutix Inc. stock expected to show significant growthEntry Signal Data Feed With Low Risk - jammulinksnews.com
How volatile is Ocular Therapeutix Inc. stock compared to the marketBest Dividend Data Feed To Watch Now - jammulinksnews.com
Does Ocular Therapeutix Inc. stock perform well during market downturnsLow Risk Guidance That Work - jammulinksnews.com
Using data filters to optimize entry into Ocular Therapeutix Inc.Risk Managed Intraday Trade Alerts Increase in Volume - metal.it
Quantitative breakdown of Ocular Therapeutix Inc. recent moveReliable Alerts for Daily Stock Movers Released - metal.it
Ocular Therapeutix Inc. Reaches Critical Trendline SupportTrend Analysis for Safer Trades Gains Popularity - metal.it
Can Ocular Therapeutix Inc. Rally Enough to Break EvenTechnical Entry Strategy for Beginners Explained - metal.it
Ocular Therapeutix™ to Report Second Quarter 2025 Financial Results on August 5, 2025 - GlobeNewswire
After Leaping 31% Ocular Therapeutix, Inc. (NASDAQ:OCUL) Shares Are Not Flying Under The Radar - simplywall.st
Ocular Therapeutix Sets Q2 Earnings Date: Key Retina Biotech Updates Coming August 5 - Stock Titan
What is the risk reward ratio of investing in Ocular Therapeutix Inc. stockFinancial News Planner For Beginners - jammulinksnews.com
Ocular Hypertension Clinical Trials, Companies, Therapeutic - openPR.com
Ocular Hypertension Clinical Trials, Companies, Therapeutic Assessment, Therapies, Treatment Algorithm, Pipeline Analysis | Nicox, Qlaris Bio, TheratOcular Biotek Co., Ltd., Ocular Therapeutix, Whitec - Barchart.com
Can Ocular's AXPAXLI Redefine Outcomes In Wet AMD? - RTTNews
Is Ocular Therapeutix Inc. stock overvalued or undervaluedRapidly growing investment returns - jammulinksnews.com
Is Ocular Therapeutix Inc. a growth stock or a value stockDynamic capital growth - jammulinksnews.com
Is it the right time to buy Ocular Therapeutix Inc. stockFree Investment Community - jammulinksnews.com
How strong is Ocular Therapeutix Inc. company’s balance sheetUnlock your portfolio’s hidden potential - jammulinksnews.com
What analysts say about Ocular Therapeutix Inc. stockExceptional market positioning - PrintWeekIndia
Is Ocular Therapeutix Inc. a good long term investmentPhenomenal trading returns - PrintWeekIndia
What drives Ocular Therapeutix Inc. stock priceExceptional profit velocity - Autocar Professional
Ocular Therapeutix Inc. Stock Analysis and ForecastFastest-growing stock picks - PrintWeekIndia
Ocular Therapeutix stock hits 52-week high at $11.78 - Investing.com
Ocular Therapeutix stock hits 52-week high at $11.78 By Investing.com - Investing.com Canada
Ocular Therapeutix™ to Participate in Upcoming Scientific Conferences - GlobeNewswire
Ocular Therapeutix, Inc.'s (NASDAQ:OCUL) P/S Is Still On The Mark Following 42% Share Price Bounce - 富途牛牛
Ocular Therapeutix Announces Participation in Upcoming Scientific Conferences Focused on Retina Innovation - Quiver Quantitative
Ocular Therapeutix Participates in Upcoming Scientific Conferences - AInvest
Ocular Therapeutix Unveils Breakthrough Diabetic Retinopathy Treatment Data Across 3 Major Eye Conferences - Stock Titan
Published on: 2025-07-20 23:34:06 - PrintWeekIndia
(OCUL) Trading Report - news.stocktradersdaily.com
Ocular Therapeutix Inc Azioni (OCUL) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.93%
0.15%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):